Cent Eur J Public Health 2004, 12(3):131-133
The Results of Dietary Advice on Lipoprotein Levels among Patients Attending for Lipid-lowering drugs
- Department of General Practice, University of Brussels, Belgium
The aim of this study was to evaluate the changes in fasting lipoproteins levels before and after a dietary advice among the patients attending for a lipid-lowering treatment.
In total 286 patients attending for reimbursement of a lipid-lowering drug were recorded at two regional health insurance offices. Lipid levels measured at least three months after the dietary advice were compared with those before the dietary advice.
The mean age of the included patients was 61 years. The average fasting total cholesterol (TC) was 7.4 mmol/l before the dietary advice as well as after the dietary advice. Fasting TC did not decrease with the dietary advice in 51% of the included patients. In the logistic regression not one of the studied factors was correlated with a successful dietary advice.
Half of the patients receiving lipid-lowering drugs in Belgium were not able to decrease their TC with dietary advice before the initiation of the treatment.
Klíčová slova: diet, dietary advice, cholesterol, Belgium, treatment guidelines, lipid-lowering treatment
Vloženo: 10. říjen 2004; Revidováno: 5. březen 2004; Přijato: 5. březen 2004; Zveřejněno: 1. září 2004 Zobrazit citaci
Reference
- Adult Treatment Panel III, Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA, 2001; 285: 2486-2497.
Přejít k původnímu zdroji...
- Wood D, De Backer G, Faergeman O, Graham I, Mancia G., Pyorala K: Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis, 1998; 140: 199-270.
Přejít k původnímu zdroji...
- Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM for the SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J, 2003; 24: 987-1003.
Přejít k původnímu zdroji...
- Tang JL, Armitage JM, Lancaster T, Silagy CA, Fowler GH, Neil HA: Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects. Brit Med J, 1998; 316: 1213-20.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Ebrahim S, Davey Smith G: Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev (2),2000,CD001561.
Přejít k původnímu zdroji...
- FriedewaldWT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18: 499-502.
Přejít k původnímu zdroji...
- Stone NJ. Lipid management: current diet and drug treatment options. Am J Med, 1996; 101: S40-48.
Přejít k původnímu zdroji...
- Martens LL, Rutten FF, Erkelens DW, Ascoop CA: Clinical benefits and cost-effectiveness of lowering serum cholesterol levels: the case of simvastatin and cholestyramine in The Netherlands.Am J Cardiol, 1990; 65: F27-32.
Přejít k původnímu zdroji...
- The LIPID Study Group. Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up. Lancet, 2002; 359: 1379-1387.
Přejít k původnímu zdroji...
Přejít na PubMed...